Olympus Innovation Ventures

About The Fund

Olympus Innovation Ventures (OIV) is an investment fund that focuses on customer-driven solutions in the fields of medical devices, diagnostics, and digital health. They aim to complement and extend market-leading endoscopic solutions. With an emphasis on HealthTech, Fitness, Medical Devices, Hospital Services, Healthcare, Wellness, and Consumer industries, Olympus Innovation Ventures is dedicated to revolutionizing medical solutions. They pride themselves on leveraging over a century of medtech leadership to support founders through crucial stages such as clinical validation, regulatory approval, and global commercial distribution. Entrepreneurs benefit from OIV's technical and clinical expertise, scale, and strong relationships with healthcare systems worldwide. The fund specializes in stages ranging from Seed to Series B, with Olympus Innovation Ventures being open to leading or joining funding rounds. They typically invest between $100,000 and $5,000,000, with a sweet spot of around $1,500,000 for investments. Annually, they aim to make three to five investments globally in clinical areas like Gastroenterology, Respiratory, Urology, ENT, Gynecology, and General Surgery. Partnering with Touchdown Ventures, OIV operates with a dedicated team to manage the fund, employing over 50 investment professionals who operate CVC funds for more than 15 corporations. Their website also highlights recent investments, demonstrating a commitment to innovation, such as an investment in Alimetry, which integrates AI in wearables for gut health diagnosis. Their portfolio companies include Eximis, Neuspera Medical, On Target Labs, Universal Diagnostics, and Virgo, which cover a range of solutions from specimen segmentation and neuromodulation to intraoperative imaging and diagnostic services.